These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 33845483)

  • 1. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
    Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
    Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
    Davies JP; Almasy KM; McDonald EF; Plate L
    ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.
    Feng L; Yin YY; Liu CH; Xu KR; Li QR; Wu JR; Zeng R
    J Mol Cell Biol; 2020 Jun; 12(12):946-957. PubMed ID: 32642770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
    Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
    J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial and temporal roles of SARS-CoV PL
    Yan S; Wu G
    FASEB J; 2021 Jan; 35(1):e21197. PubMed ID: 33368679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2.
    Prates ET; Garvin MR; Pavicic M; Jones P; Shah M; Demerdash O; Amos BK; Geiger A; Jacobson D
    Mol Biol Evol; 2021 Jan; 38(2):702-715. PubMed ID: 32941612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
    Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
    Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
    Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
    Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
    Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
    Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ORF8a as a viroporin in SARS-CoV-2 infection?
    Zandi M
    Cytokine Growth Factor Rev; 2021 Oct; 61():1. PubMed ID: 34362671
    [No Abstract]   [Full Text] [Related]  

  • 17. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.
    Ma-Lauer Y; Carbajo-Lozoya J; Hein MY; Müller MA; Deng W; Lei J; Meyer B; Kusov Y; von Brunn B; Bairad DR; Hünten S; Drosten C; Hermeking H; Leonhardt H; Mann M; Hilgenfeld R; von Brunn A
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):E5192-201. PubMed ID: 27519799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
    Praissman JL; Wells L
    Mol Cell Proteomics; 2021; 20():100103. PubMed ID: 34089862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
    Zhou N; Bao J; Ning Y
    BMC Bioinformatics; 2021 Jan; 22(1):18. PubMed ID: 33413085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular host factors for SARS-CoV-2 infection.
    Baggen J; Vanstreels E; Jansen S; Daelemans D
    Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.